Announcements Trials
Browse Landscape

Phase

Phase 2 6Phase 3 3Phase NA 2Phase 4 1Phase 2/3 1

Status

Recruiting 23Active not recruiting 12Completed 8Not yet recruiting 7Unknown 6Terminated 5Withdrawn 4

Sponsor Class

OTHER 5FED 1

Study Type

Interventional 6

Sponsor

Cancer Type

Genitourinary 6

Conditions

Prostatic Neoplasms 5Oligometastatic Prostate Cancer 1

Interventions

Cisplatin 270Oxaliplatin 195Carboplatin 191Capecitabine 184Docetaxel 178apatinib 164Paclitaxel 163Bevacizumab 159Gemcitabine 156Radiotherapy 147camrelizumab 146Fluorouracil 144Cyclophosphamide 126Irinotecan 120Drug Therapy 119sintilimab 108Etoposide 99anlotinib 90S 1 (combination) 89Leucovorin 86pembrolizumab 85toripalimab 78Pemetrexed 78Doxorubicin 77tislelizumab 76Dexamethasone 71Trastuzumab 65Neoadjuvant Therapy 65Rituximab 62Cetuximab 62

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Phase 2 × Unknown × Androgen Antagonists × Clear all
NCT05223582 2023-12-08

Fluzoparib and Abiraterone in the preSurgery Treatment of Prostate Cancer: FAST Trial

Fudan University

Phase 2 Unknown
34 enrolled
Genitourinary

Prostatic Neoplasms

NCT03940235 2023-06-28

RADIOSA

European Institute of Oncology

Phase 2 Unknown
150 enrolled
Genitourinary

Oligometastatic Prostate Cancer

NCT03845751 2023-01-12

ENHANCE

Institut Mutualiste Montsouris

Phase 2 Unknown
20 enrolled
Genitourinary

Prostatic Neoplasms

NCT05249712 2023-01-03

Efficacy and Safety of Darolutamide Combined With ADT in High-risk/Very High-risk Localized Prostate Cancer

The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School

Phase 2 Unknown
30 enrolled
Genitourinary

Prostatic Neoplasms

NCT03061643 2022-03-08

An Open Label Phase II Study of Biweekly Docetaxel Plus Androgen-Deprivation Therapy in Patients With Previously-Untreated, Metastatic, Prostatic Adenocarcinoma

Samsung Medical Center

Phase 2 Unknown
42 enrolled
Genitourinary

Prostatic Neoplasms

NCT04489745 2020-07-28

Stereotactic Body Radiotherapy (SBRT) for Localized Prostate Cancer

VA Greater Los Angeles Healthcare System

Phase 2 Unknown
72 enrolled
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡